respectively, in the intention-to-treat analysis (P=0.014). Despite the high metronidazole 117 resistance after two treatment failures, the eradication rate in the patients with was as high 118 as 84% in this patient cohort (Table 3) .
119
Adverse events and compliance
120
The adverse event occurred in 17 patients (22.9%). There was no significant difference 121 between two groups in adverse events (25.6% vs. 29.2%, p=0.758) ( Table 2 ). The greatest 122 side effect from the use of medications was the digestive system such as the presence of 123 nausea, abdominal pain and constipation ( 
204
There were some limitations in this study. First, the study sample size was small. Second,
205
we were unable to turn this study into a randomized trial because we felt it was not ethical 
235
The absence of H. pylori after eradication therapy was defined as a negative result of urea 236 breath test at 8 weeks (9, 37).
237
The primary outcome variables are the eradication rate, presence of adverse events, and Per-proto ol . % / . % / .
Adverse eve t . % / . % / .
Co plia e % / % / - Ta 
